{"schema_version":"alpha-profile-public-v1","slug":"harold-e-selick","canonical_url":"https://registry.alpha.ac/people/harold-e-selick","as_of":"2026-09-22T02:43:43.760279+00:00","published_at":"2026-09-02T02:37:21.264628+00:00","last_reviewed_at":"2026-05-10T12:22:17.21+00:00","identity":{"display_name":"Harold E. Selick","headshot_url":null,"headshot_media":null,"profile_kind":"director","role_tags":["director","executive"],"current_role":{"company_name":"Protagonist Therapeutics, Inc","company_slug":"protagonist-therapeutics-inc","exchange":"NASDAQ","ticker":"PTGX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2009-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","effective_date":"2025-04-29","last_checked_at":"2026-05-09T06:24:26.411+00:00"}},"photo_match":null},"assurance":{"is_claimed":false,"status":"unverified","assurance_level":null,"method":null,"verified_at":null,"expires_at":null},"claiming":{"eligible":true,"label":"Is this you? Claim your Alpha Profile","claim_url":"https://terminal.alpha.ac/claim-profile?person=harold-e-selick","suggest_edit_label":"Suggest an edit","suggest_edit_url":"https://terminal.alpha.ac/claim-profile?person=harold-e-selick&mode=suggest","canonical_record_will_be_reused":true,"canonical_facts_owner_controlled":false},"presentation":{"schema_version":"alpha-profile-presentation-v1","state":"alpha_editorial","version":0,"published_at":null,"headline":null,"headline_evidence":null,"location":null,"photo":null,"cover":null,"about":["Dr. Selick has served on the Board since February 2009 and currently serves as Chairman. He is CEO of Hinge Bio, Inc. and previously served as CEO of Threshold Pharmaceuticals and held roles at UCSF and Sofinnova Ventures. He holds a B.A. in Biophysics and Ph.D. in Biology from the University of Pennsylvania."],"links":[],"sources":[],"featured":[],"competencies":[],"board_preferences":null,"board_service":[{"organization":"Protagonist Therapeutics, Inc","organizationId":"protagonist-therapeutics-inc","title":"Director","period":"2009-01-01 · current","evidenceLabel":"sec_proxy","evidenceState":"verified","sourceUrl":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm"}],"experience":[],"education":[],"credentials":[],"section_order":null,"hidden_sections":[],"limitations":["Presentation fields do not alter independently verified Alpha Profile facts.","Owner-supplied résumé records retain their field-level evidence state.","Only confirmed company_person_roles with public evidence. Website governed_site_fallback rows are not invented. about/links are stored people.profile_summary/bio and linkedin_url only. Dates stay undisclosed when the role has no start_date. SoFi Bank is not SoFi Technologies."]},"presentation_authority":"confirmed_company_person_roles","roles":[{"company_name":"Protagonist Therapeutics, Inc","company_slug":"protagonist-therapeutics-inc","exchange":"NASDAQ","ticker":"PTGX","role_category":"director","title":"Director","committee":null,"is_board_chair":false,"is_independent":true,"valid_from":"2009-01-01","valid_to":null,"is_current":true,"verification_status":"confirmed","confidence":0.85,"evidence":{"source_type":"sec_proxy","source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","effective_date":"2025-04-29","last_checked_at":"2026-05-09T06:24:26.411+00:00"}}],"claims":[{"claim_type":"ai_ml_experience","claim_value":false,"claim_text":"Proxy extraction classified AI/ML experience for Harold E. Selick as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-10T12:22:17.370412+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PTGX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-10T12:22:17.264836+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"board_role","claim_value":"Chair","claim_text":"Harold E. Selick currently serves as Chair at Protagonist Therapeutics.","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.92,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-10T12:22:17.335749+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PTGX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-10T12:22:17.264836+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"committee_assignments","claim_value":["Compensation","Nominating/Governance","Research"],"claim_text":"Harold E. Selick serves on Compensation, Nominating/Governance, Research.","claim_state":"verified","valid_from":"2025-04-29","valid_to":null,"confidence":0.88,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-10T12:22:17.352372+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PTGX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-10T12:22:17.264836+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_company","claim_value":"Hinge Bio, Inc.","claim_text":"Harold E. Selick is linked to Hinge Bio, Inc. as an operating executive.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-10T12:22:17.472683+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PTGX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-10T12:22:17.264836+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"current_executive_role","claim_value":"Chief Executive Officer","claim_text":"Harold E. Selick is also listed as Chief Executive Officer.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.85,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-10T12:22:17.456522+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PTGX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-10T12:22:17.264836+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"cybersecurity_experience","claim_value":false,"claim_text":"Proxy extraction classified cybersecurity experience for Harold E. Selick as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-10T12:22:17.407121+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PTGX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-10T12:22:17.264836+00:00","relation":"supports","excerpt_locator":null}]},{"claim_type":"technology_background","claim_value":false,"claim_text":"Proxy extraction classified technology background for Harold E. Selick as false.","claim_state":"verified","valid_from":null,"valid_to":null,"confidence":0.72,"source_tier":3,"verification_status":"confirmed","last_reviewed_at":"2026-05-10T12:22:17.390528+00:00","version":1,"evidence":[{"source_name":"SEC EDGAR","document_title":"PTGX DEF 14A director slate","source_type":"sec_filing","source_tier":3,"source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","published_at":"2025-04-29T00:00:00+00:00","last_checked_at":"2026-05-10T12:22:17.264836+00:00","relation":"supports","excerpt_locator":null}]},{"subject":"alpha:person:harold-e-selick","claim_type":"board_service","claim_value":{"tags":[],"title":"Director","period":"2009-01-01 · current","organization":"Protagonist Therapeutics, Inc","organization_id":"protagonist-therapeutics-inc"},"claim_text":"Director at Protagonist Therapeutics, Inc (2009-01-01 · current)","valid_from":null,"valid_to":null,"verification_status":"confirmed","date_precision":"period_text_only","evidence":[{"source_url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","label":"sec_proxy","evidence_state":"verified"}],"claim_state":"confirmed","version":1}],"network":{"schema_version":"alpha-profile-network-public-v1","relationships":[],"relationship_pathfinding":false,"authentication_prompt":"Sign in to see how you're connected.","limitations":["Representative factual associations only.","Shared contexts do not assert personal acquaintance.","Anonymous graph traversal is not available."]},"permissions":{"classification":"open_public_projection","public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false},"limitations":["Only permissioned public claims and evidence are included.","Absence of a claim is not evidence that the underlying fact is false.","Public retrieval does not grant model-training or redistribution rights.","Private relationships and Council activity are excluded."],"structured_data":{"@context":"https://schema.org","@type":"ProfilePage","@id":"https://registry.alpha.ac/people/harold-e-selick#profile","url":"https://registry.alpha.ac/people/harold-e-selick","dateModified":"2026-05-10T12:22:17.21+00:00","mainEntity":{"@type":"Person","@id":"https://registry.alpha.ac/people/harold-e-selick#person","name":"Harold E. Selick","url":"https://registry.alpha.ac/people/harold-e-selick","jobTitle":"Director","worksFor":{"@type":"Organization","name":"Protagonist Therapeutics, Inc","tickerSymbol":"NASDAQ: PTGX"},"affiliation":[{"@type":"OrganizationRole","roleName":"Director","startDate":"2009-01-01","memberOf":{"@type":"Organization","name":"Protagonist Therapeutics, Inc","url":"https://registry.alpha.ac/companies/protagonist-therapeutics-inc","tickerSymbol":"NASDAQ: PTGX"}}]},"isBasedOn":[{"@type":"CreativeWork","url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925041206/tm252374-2_def14a.htm","name":"PTGX DEF 14A director slate"}],"mainEntityOfPage":"https://registry.alpha.ac/people/harold-e-selick"},"trust":{"schema_version":"alpha-profile-trust-v1","verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"aggregation":{"schema_version":"alpha-claim-aggregation-v1","published_claim_count":9,"under_review_claim_count":0,"owner_supplied_claim_count":0,"evidence_record_count":3,"distinct_source_count":1,"conflicts":[],"conflict_count":0,"headline_conflict_count":0,"internal_review_conflict_count":0,"contradiction_types":[],"headline_conflict_types":[],"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":9,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed."},"coverage":{"schema_version":"alpha-coverage-metric-v1","published_claims":9,"corroborated_claims":0,"sources":3,"distinct_sources":1,"role_claims":1,"last_reviewed_at":"2026-05-10T12:22:17.21+00:00","observed_at":"2026-09-22T02:43:43.760279+00:00","freshness_days":135}},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"}},"projection":{"schema_version":"alpha-profile-projection-v5","entity":{"kind":"person","slug":"harold-e-selick","canonical_url":"https://registry.alpha.ac/people/harold-e-selick"},"publication":{"published_at":"2026-09-02T02:37:21.264628+00:00","last_reviewed_at":"2026-05-10T12:22:17.21+00:00","as_of":"2026-09-22T02:43:43.760279+00:00"},"representations":{"html":{"href":"https://registry.alpha.ac/people/harold-e-selick","media_type":"text/html"},"json":{"href":"https://registry.alpha.ac/api/public/profiles/harold-e-selick","media_type":"application/json"},"markdown":{"href":"https://registry.alpha.ac/people/harold-e-selick.md","media_type":"text/markdown"},"structured_data":{"embedded":true,"media_type":"application/ld+json"},"share_image":null},"permissions":{"public_retrieval":true,"agent_retrieval":true,"redistribution":false,"model_training":false,"relationship_pathfinding":false,"direct_contact":false}}}